USPTO serial 79260990
BRIGHTPLEX
Reviewed by CopyMark Law Group
Reg. 5958367Status 709
- Filing date
- Status date
- Registration date
- Jan 14, 2020
- Examiner
- PENDLETON, CAROLYN A
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BRIGHTPLEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy Dell Nichols
Timothy Dell Nichols Workman Nydegger60 East South Temple, Suite 1000Salt Lake City, UT 84111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in in vitro testing, for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; chemical preparations for medical and pharmaceutical use for use in in vitro testing, for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; biological reagents for medical use for providing diagnostic or identification information of biological systems; immunological reagents for medical use; biological reagents for medical diagnosis; medical diagnostic kits comprising biological markers, reagents and medical tests for diagnostic purposes, for testing biological tissue samples; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis | SECTION 71 - CANCELLED | — |
| 009 | Recorded software for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatment and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition | SECTION 71 - CANCELLED | — |
| 042 | Research, development, technical design and scientific testing services in the field of oncology; industrial analysis and research services in the field of oncology; clinical trial services for others; tests in laboratories, namely, analysis of biological mechanisms of actions, biomarkers and signatures for research in biology purposes; development of quality control testing methods for others; research, development, technical design, testing, consulting and analysis services in the field of immunology and oncology; research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; research services in the field of immune repertoire analysis and the genome; design and development of software in the field of biology | SECTION 71 - CANCELLED | — |
| 044 | Medical analysis services, namely, analysis of tumor, cancer or equivalent medical condition; medical assistance; health care services; medical therapeutic services; medical diagnostics, diagnostics in the field of medicine; genetic and tissue analysis services for medical purposes; medical testing services for the detection, quantification, localization of proteins or cells on a section of biological tissue for the purposes of medical diagnosis, namely, analyzing the immune contexture of a tumor | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Veracyte
- Other trademarks owned by HalioDx
- Other trademarks owned by HalioDx
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named BRIGHTPLEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 31, 2026 | C71T | CANCELLED SECTION 71 | — |
| Aug 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 14, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 12, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 22, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 24, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 24, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 14, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 14, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 29, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 29, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 26, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 9, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 9, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 9, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 19, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 18, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 18, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 11, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 9, 2019 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jul 22, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 22, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 30, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 29, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 25, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 20, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 13, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |